2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2022-10, Vol.80 (14), p.1366-1418
Main Authors: Lloyd-Jones, Donald M, Morris, Pamela B, Ballantyne, Christie M, Birtcher, Kim K, Covington, Ashleigh M, DePalma, Sondra M, Minissian, Margo B, Orringer, Carl E, Smith, Jr, Sidney C, Waring, Ashley Arana, Wilkins, John T
Format: Article
Language:English
Subjects:
Anticholesteremic Agents - therapeutic use
Cardiology
Cardiovascular Diseases - drug therapy
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - prevention & control
Cholesterol, LDL
Consensus
Ezetimibe
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
United States - epidemiology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1558-3597
DOI:10.1016/j.jacc.2022.07.006